JENNIFER BURGESS: Open Payments
NPI 1912257098 · PORT ST LUCIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 37 payments from 18 companies in 2025. Trend: 2023 $664 · 2024 $831 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $112 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $88 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Eisai Inc. | 2 | $55 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| ABBVIE INC. | 3 | $49 |
| Corcept Therapeutics | 2 | $47 |
| Novo Nordisk Inc | 2 | $43 |
| PFIZER INC. | 2 | $38 |
Products named: OTEZLA, XIFAXAN, GEMTESA, Leqembi, TRELEGY ELLIPTA, LEQVIO, Korlym, QULIPTA.
Industry payments across FL — which companies pay providers there.
